These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
111 related items for PubMed ID: 3091370
1. Crossed chemoprophylaxis assay between adriamycin and cis-platinum in recurrent superficial bladder tumor. Llopis B, Gallego J, Mompó JA, Boronat F, Alonso M, Moreno B, Jiménez JF. Eur Urol; 1986; 12(4):253-6. PubMed ID: 3091370 [Abstract] [Full Text] [Related]
2. Thiotepa versus adriamycin versus cis-platinum in the intravesical prophylaxis of superficial bladder tumors. Llopis B, Gallego J, Mompó JA, Boronat F, Jiménez JF. Eur Urol; 1985; 11(2):73-8. PubMed ID: 3924624 [Abstract] [Full Text] [Related]
3. [Comparative study of adriamycin and thiotepa in the chemoprophylaxis of superficial bladder tumors]. Salinas Sánchez AS, Moreno Avilés J, Pérez Albacete M, Salmerón Lopez-Rua J, Guardiola Más A, Server Falgas G. Actas Urol Esp; 1989; 13(2):99-102. PubMed ID: 2499166 [Abstract] [Full Text] [Related]
5. [Comparative study of 62 patients randomly treated with adriamycin or cisplatin as chemoprophylaxis of their superficial bladder carcinoma]. Iborra Juan I, Monrós Lliso JL, Ricós Torrent JV, Mazcuñan Fuentes F, Casanova Ramón-Borja J, Solsona Narbón E. Actas Urol Esp; 1988; 12(1):20-4. PubMed ID: 3389211 [No Abstract] [Full Text] [Related]
6. [Comparative study of thiotepa, adriamycin and cisplatin in the prophylaxis of recurrence of superficial bladder carcinoma in a group of 217 patients]. Llopis B, Gallego J, Boronat F, Moreno B, Mompó JA, Jiménez JF. Actas Urol Esp; 1986; 10(4):225-30. PubMed ID: 3092589 [No Abstract] [Full Text] [Related]
7. [Comparative study of 3 series of patients treated respectively with thiotepa, adriamycin and cisplatin]. Nogueira March JL, Ojea A, Jamardo D, Figueiredo L. Actas Urol Esp; 1984; 8(4):325-8. PubMed ID: 6435407 [No Abstract] [Full Text] [Related]
8. [Prognostic factors and risk of recurrence in a series of 385 patients with superficial bladder carcinoma treated with thiotepa, adriamycin or cisplatin]. Llopis B, Sánchez A, Boronat F, Gallego J, Moreno B, Alonso M, Martínez R, Vera CD, Jiménez JF. Arch Esp Urol; 1987 Apr; 40(3):159-64. PubMed ID: 3113347 [No Abstract] [Full Text] [Related]
9. Prophylactic chemotherapy of superficial transitional cell bladder carcinoma: an EORTC randomized trial comparing thiotepa, an epipodophyllotoxin (VM26) and TUR alone. Schulman CC, Robinson M, Denis L, Smith P, Viggiano G, de Pauw M, Dalesio O, Sylvester R. Eur Urol; 1982 Apr; 8(4):207-12. PubMed ID: 6807679 [Abstract] [Full Text] [Related]
10. Treatment of superficial bladder tumors in a controlled trial with thio-TEPA versus adriamycin. Horn Y, Eidelman A, Walach N, Yuval E, Markowitz A. J Surg Oncol; 1984 Sep; 27(1):67-9. PubMed ID: 6434883 [Abstract] [Full Text] [Related]
11. Bacillus Calmette-Guerin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder cancer. Martínez-Piñeiro JA, Jiménez León J, Martínez-Piñeiro L, Fiter L, Mosteiro JA, Navarro J, García Matres MJ, Cárcamo P. J Urol; 1990 Mar; 143(3):502-6. PubMed ID: 2106041 [Abstract] [Full Text] [Related]
12. Intravesical therapy comparing BCG, adriamycin, and thiotepa in 200 patients with superficial bladder cancer: a randomized prospective study. Martinez-Pineiro JA, Jimenez León J, Martinez-Pineiro L, Fiter L, Mosteiro JA, Navarro J, García Matres MJ, Cárcamo P. Prog Clin Biol Res; 1989 Mar; 310():237-52. PubMed ID: 2505269 [Abstract] [Full Text] [Related]
13. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy. Tzai TS, Chow NH, Lin JS, Yang WH, Tong YC. Anticancer Res; 1998 Mar; 18(6B):4717-21. PubMed ID: 9891547 [Abstract] [Full Text] [Related]
14. Retrospective analysis of transurethral resection, second-look resection, and long-term chemo-metaphylaxis for superficial bladder cancer: indications and efficacy of a differentiated approach. Schulze M, Stotz N, Rassweiler J. J Endourol; 2007 Dec; 21(12):1533-41. PubMed ID: 18186695 [Abstract] [Full Text] [Related]
15. [Superficial bladder tumors. Preliminary results of a prospective study comparing endovesical BCG, adriamycin and thio-tepa]. Martínez-Piñeiro JA, de la Peña J, Hidalgo L, Cisneros J, Jiménez León J, Machuca J, Perdices C. Arch Esp Urol; 1985 Dec; 38(6):545-53. PubMed ID: 3938633 [No Abstract] [Full Text] [Related]
16. Influence of thiotepa and doxorubicin instillation at time of transurethral surgical treatment of bladder cancer on tumor recurrence: a prospective, randomized, double-blind, controlled trial. Zincke H, Utz DC, Taylor WF, Myers RP, Leary FJ. J Urol; 1983 Mar; 129(3):505-9. PubMed ID: 6403716 [Abstract] [Full Text] [Related]
17. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis. Huncharek M, McGarry R, Kupelnick B. Anticancer Res; 2001 Mar; 21(1B):765-9. PubMed ID: 11299841 [Abstract] [Full Text] [Related]
18. Local adriamycin treatment for prevention of recurrence of superficial bladder tumours. Kondás J, Szentgyörgyi E, Szöke D. Int Urol Nephrol; 1988 Mar; 20(6):611-5. PubMed ID: 3229933 [Abstract] [Full Text] [Related]
19. Cooperative studies of chemoprophylaxis after transurethral resection of bladder tumors. Pavone-Macaluso M, Tripi M, Ingargiola GB. Cancer Chemother Pharmacol; 1983 Mar; 11 Suppl():S16-21. PubMed ID: 6416698 [Abstract] [Full Text] [Related]
20. [Intra-arterial infusion chemotherapy for superficial bladder cancer]. Kobayashi M, Sugaya Y, Yuzawa M, Morita T, Kobayashi Y, Tokue A. Hinyokika Kiyo; 1999 Sep; 45(9):605-7. PubMed ID: 10540704 [Abstract] [Full Text] [Related] Page: [Next] [New Search]